Skip to Main Content

Paper Details

Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment.
Drug Resist Updat
10
2023
Omicron sublineage, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 sequences, anti-Spike mAbs, anti-Spike monoclonal antibodies, immunocompromised, mAb, patient, patients
Author NameAffiliation
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
  • 1 - 2

Datasets

Release 1.2